Resources
Summary statistics of a meta GWAS of odour identification. For each investigated odour, combined and sex-stratified results are uploaded. GWAS catalogue format for summary statistics is used. Only genetic variants present in at least two studies are included.
Included columns:
- chromosome
- base_pair_location (hg38)
- effect_allele
- other_allele
- beta
- standard_error
- effect_allele_frequency
- p_value
- variant_id
- info
- n
- n_stud
- I2
- het_chi_sq
- het_df
- het_p_value
- direction ...
Submitter: Franz Förster
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
Study: GWAMA Olfaction
The model can be opened with the 3LGM² - Three-layer Graph-based meta modelling tool, a software to support the modelling of information systems in health care in strategic information management. See also the product page in ToolPool Gesundheitsforschung (in German).
Submitter: Sebastian Stäubert
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: 3LGM²
Study: 3LGM² Tool
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MI-Lab Lerneinheiten
Study: Lisa's liver tumor study
Die enthaltenen ZIPs enthalten FHIR-Ressourcen Patient und Fall als Konvertierungen aus dem MIMIC-IV Demodatensatz.
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MI-Lab Lerneinheiten
Study: MI-Lab Übung 02 CSV-to-FHIR
For requesting access to the data, please fill out and sign the Data Access Agreement document and send it to the SysMedPD Metabolomics Data Access Committee (christine_klein@uni-luebeck.de).
Submitter: Silke Szymczak
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Systems Medicine of Mitochondrial Parkinson’s D...
Study: SysMedPD metabolomics study
Clinical characteristics of Parkinson's Disease patients and healthy controls
Submitter: Silke Szymczak
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Systems Medicine of Mitochondrial Parkinson’s D...
Study: SysMedPD metabolomics study
Targeted metabolomics data from blood samples using five different platforms (amines, acylcarnitines, organic acids, signaling lipids and lididomics)
Submitter: Silke Szymczak
Resource type: Metabolite Profiling
Technology type: Mass Spectrometry
Investigation: Systems Medicine of Mitochondrial Parkinson’s D...
Study: SysMedPD metabolomics study
This document is an excerpt of the author’s bachelor thesis.
Submitter: Matthias Löbe
Biological problem addressed: Model Analysis Type
Investigation: FAIR Software Registries
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: EHDS in 3LGM²
Submitter: Matthias Löbe
Biological problem addressed: Model Analysis Type
Investigation: EHDS in 3LGM²
Summary Statistics used in publication
Submitter: Katrin Horn
Resource type: Genome Wide Association
Technology type: Technology Type
Investigation: OMICS Investigations
Study: GWAMA vaspin
Polar test data for individual workpackages with different FHIR structure.
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Collection of general FHIR test data
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Allgemein
Alle einzelnen Datensätze sind aufgeteilt in jeweils (maximal) 1000 Patienten, die jeweils als json.zip
und ndjson
verfügbar sind.
Die json.zip
und ndjson
beinhalten jeweils bis zu 1000 Transaktion-Bundles mit jeweils 1 Patienten.
Die gleichnamige Excel-Datei ist die Vorlage zum Generieren JSON-Dateien.
VHF-Testdaten_01
Ursprüngliche Vorhofflimmern (VHF) Testdaten sind Patienten
- unterschiedlichen Alters (17 bis 83 Jahre, davon 3300 Patienten mit Alter > 65 Jahre)
- mit ...
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Submitter: Katrin Horn
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
A collection of Bulletins of the Institute for Medical Informatics, Statistics and Epidemiology (IMISE) about the COVID-19 pandemic in Leipzig and Saxony. This work was funded in the framework of the project SaxoCOV (Saxonian COVID-19 Research Consortium, SaxoCOV was financed by the Free State of Saxony).”
To provide data input and result from a scRNA-Seq integration workflow
Submitter: Holger Kirsten
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
Submitter: Andreas Kühnapfel
Biological problem addressed: Genome Scale
Investigation: OMICS Investigations
Study: GWAS Body Scanner Measures
Submitter: Matthias Löbe
Biological problem addressed: Model Analysis Type
Investigation: FAIR4Health Information Architecture
Study: 3LGM² model for FAIR4Health
Submitter: Matthias Löbe
Biological problem addressed: Model Analysis Type
Investigation: FAIR4Health Information Architecture
Study: 3LGM² model for FAIR4Health
Submitter: Mona Perbix
Biological problem addressed: Model Analysis Type
Investigation: FAIR4Health Information Architecture
Study: 3LGM² model for FAIR4Health
The 3LGM² reference model for the FAIR4Health information architecture is based on the 3LGM² Metamodel. A graphical export of the different layers and a matrix view of the inter-level relationships is provided. However the 3LGM² tool is required for an interactive display of the model and additional functions.
Submitter: Matthias Löbe
Biological problem addressed: Model Analysis Type
Investigation: FAIR4Health Information Architecture
Study: 3LGM² model for FAIR4Health
Clinical data extracted from local EHR systems.
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FAIR4Health Pathfinder Case Studies
Example study for people with hypertension or obesity as inclusion criteria. This ontology uses the Core Ontology of Phenotypes as a general phenotypic model.
Submitter: Christoph Beger
Biological problem addressed: Model Analysis Type
Investigation: Phenotype Knowledge Model
Submitter: Katrin Horn
Resource type: Gene Expression Profiling
Technology type: Technology Type
Investigation: OMICS Investigations
We are releasing the summary data from our GWAMA of PCSK9 levels, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation: tba
When using this data acknowledge the source as follows: 'Data on PCSK9 has been downloaded from https://www.health-atlas.de/data_files/551.'
For any enquiries about the datasets, please contact Janne Pott (janne.pott@imise.uni-leipzig.de) ...
Submitter: Janne Pott
Resource type: Experimental Assay Type
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAMA PCSK9
We are releasing the summary data from our GWAMA of phytosterol traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation: tba
When using this data acknowledge the source as follows: 'Data on phytosterol X has been contributed by LIFE investigators and has been downloaded from https://www.health-atlas.de/assays/53.'
For any enquiries about ...
Submitter: Janne Pott
Resource type: Experimental Assay Type
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAMA Phytosterole
Summary statistics from GWAS of baPWV, bfPWV, cfPWV All samples (adjusted for age, sex and log_sys)
These data is intended for research purposes only.
Citation: tbc
When using this data acknowledge the source as follows: 'Data on PWV has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/34'
For any enquiries about the datasets, please contact Michael Rode (michael.rode@imise.uni-leipzig.de) or Markus Scholz (markus.scholz@imise.uni-leipzig.de) ...
Submitter: Michael Rode
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Pulse Wave Velocity
We are releasing the summary data from our GWAS of carotid plaque burden traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation:
When using this data acknowledge the source as follows: 'Data on carotid plaque burden has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/31 '
For any ...
Submitter: Janne Pott
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Carotid Plaque Burden
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: ACT-2
Study: ACT-2
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FLYER
Study: Flyer
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FLYER
Study: Flyer
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: ACT-2
Study: ACT-2
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: head and neck squamous cell carcinomas
Study: HNSCC
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: head and neck squamous cell carcinomas
Study: HNSCC
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Covid-19
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Covid-19
This assay bundles all synthetic FHIR data of the PhenoMan evaluation. The data arised from a subset of a Synthea(TM) generated data set. We truncated some resource types like Encounter and Provider to reduce the size of the data set and to speed up the import in a FHIR health data store.
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: Ontology-based Phenotyping
Submitter: Alexandr Uciteli
Biological problem addressed: Model Analysis Type
Investigation: Ontology-based Phenotyping
We modelled the algorithm for determining Type 2 Diabetes Mellitus (T2DM) cases presented by PheKB.org using Phenotype Manager (PhenoMan).
Submitter: Alexandr Uciteli
Biological problem addressed: Model Analysis Type
Investigation: Ontology-based Phenotyping
We are releasing the summary data from our meta-analyses of steroid hormones, to empower other researchers to examine variants or loci in which they are interested for association with these hormonal traits. These data are intended for research purposes only.
Citation: Pott et al. (2019) Genetic Association Study of Eight Steroid Hormones and Implications for Sexual Dimorphism of Coronary Artery Disease. J Clin Endocrinol Metab 104: 5008–5023. PubMed ID: 31169883
When using this data acknowledge ...
Submitter: Janne Pott
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Steroid Hormones
The primary goal of this study was to identify genetic loci associated with steroid hormone levels (cortisol, DHEA-S, testosterone, estradiol, progesterone, 17-hydroxyprogesterone, androstenedione, and aldosterone). In a secondary analysis, we searched for causal effects of steroid hormones on coronary artery disease.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
Study: GWAS Steroid Hormones
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SMARTE-R-CHOP-14
Study: SMARTE-R-CHOP-14
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SMARTE-R-CHOP-14
Study: SMARTE-R-CHOP-14
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SISPCT
Study: SISPCT
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SISPCT
Study: SISPCT
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SEXIE-R-CHOP-14
Study: SEXIE-R-CHOP-14
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SEXIE-R-CHOP-14
Study: SEXIE-R-CHOP-14
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-noRTh
Study: RICOVER-noRTh
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-noRTh
Study: RICOVER-noRTh
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-60
Study: RICOVER-60
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-60
Study: RICOVER-60
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Pegfilgrastim
Study: Pegfilgrastim
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Pegfilgrastim
Study: Pegfilgrastim
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: MegaCHOEP
Study: MegaCHOEP
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
Adjunctive hydrocortisone (HC) therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The case for septic patients without shock remains controversial. We investigated the efficacy of HC in patients with severe sepsis without shock
Restricted Trial Data
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: HYPRESS
Study: HYPRESS
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: HYPRESS
Study: HYPRESS
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MegaCHOEP
Study: MegaCHOEP
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MInT
Study: MInT
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: MInT
Study: MInT
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: DENSE-R-CHOP-14
Study: DENSE-R-CHOP-14
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: DENSE-R-CHOP-14
Study: DENSE-R-CHOP-14